Given the eyebrow-raising cash component in Celgene’s new deal with Nogra, we thought it would be fun to list the top 10 upfronts paid for experimental drugs, ranked simply according to the cash included in the upfront–no surer sign of what a company really thinks about the potential of an experimental therapy or portfolio.

…read more

Source: Show me the money: Which drugs made the top 10 list on upfront deals?


0 No comments